Finance

Lists
Q1 2027 earnings
See results
GUFICBIO:NSE
Gufic BioSciences Ltd
₹423.90
+0.40%
(+1.70) 1D
Aug 17, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for GUFICBIO...
Open
₹400.20
High
₹432.35
Low
₹400.20
Mkt. cap
42.04B
Avg. vol.
0.00
Volume
297.92K
Dividend
0.02%
Quarterly dividend
₹0.03
Ex-dividend date
Sep 22, 2025
P/E ratio
66.23
52-wk high
₹448.00
52-wk low
₹268.00
EPS
₹6.40
Shares outstanding
77.83M
No. of employees
2K
Open
₹400.20
High
₹432.35
Low
₹400.20
Mkt. cap
42.04B
Avg. vol.
0.00
Volume
297.92K
Dividend
0.02%
Quarterly dividend
₹0.03
Ex-dividend date
Sep 22, 2025
P/E ratio
66.23
52-wk high
₹448.00
52-wk low
₹268.00
EPS
₹6.40
Shares outstanding
77.83M
No. of employees
2K
News stories
From web sources and news partners
About Gufic BioSciences Ltd
CEOJayesh P. Choksi
Employees1.61K
Founded1970
Headquarters-
SectorPharmaceutical industry
Websitegufic.com
Last report
Aug 17, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
2.61B / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.37B
2.31B
2.52B
2.61B
Cost of goods sold
1.04B
1.01B
1.23B
1.15B
Cost of revenue
1.04B
1.01B
1.23B
1.15B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
374.51M
400.89M
432.36M
418.05M
Operating expense
1.03B
1.05B
889.21M
1.07B
Total operating expenses
2.07B
2.06B
2.12B
2.22B
Operating income
300.73M
252.86M
395.66M
393.58M
Other non operating income
21.16M
7.90M
-47.39M
-
EBT including unusual items
226.04M
177.20M
289.51M
300.39M
EBT excluding unusual items
226.04M
177.20M
289.55M
300.39M
Income tax expense
57.82M
52.97M
70.54M
77.27M
Effective tax rate
25.58%
29.89%
24.37%
25.72%
Other operating expenses
573.19M
573.22M
380.37M
574.07M
Net income
168.24M
124.24M
218.97M
223.13M
Net profit margin
7.10%
5.37%
8.70%
8.54%
Earnings per share
-
-
-
-
Interest and investment income
-
-
16.90M
-
Interest expense
-95.84M
-83.56M
-79.83M
-93.18M
Net interest expenses
-95.84M
-83.56M
-62.93M
-93.18M
Depreciation and amortization charges
77.73M
76.92M
76.49M
77.06M
EBITDA
378.19M
286.97M
454.81M
452.73M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps